American National Bank & Trust’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-229
| Closed | -$53.1K | – | 481 |
|
|
2024
Q2 | $53.1K | Hold |
229
| – | – | 0.01% | 317 |
|
|
2024
Q1 | $49.4K | Sell |
229
-1
| -0.4% | -$234 | 0.01% | 322 |
|
|
2023
Q4 | $59.5K | Hold |
230
| – | – | 0.01% | 272 |
|
|
2023
Q3 | $59.1K | Buy |
230
+229
| +22,900% | +$61.3K | 0.01% | 268 |
|
|
2023
Q2 | $285 | Hold |
1
| – | – | ﹤0.01% | 549 |
|
|
2023
Q1 | $278 | Sell |
1
-68
| -99% | -$18.8K | ﹤0.01% | 544 |
|
|
2022
Q4 | $19K | Sell |
69
-36
| -34% | -$10.2K | ﹤0.01% | 336 |
|
|
2022
Q3 | $28K | Buy |
105
+5
| +5% | +$1.06K | 0.01% | 281 |
|
|
2022
Q2 | $20K | Hold |
100
| – | – | ﹤0.01% | 245 |
|
|
2022
Q1 | $21K | Hold |
100
| – | – | ﹤0.01% | 258 |
|
|
2021
Q4 | $24K | Hold |
100
| – | – | ﹤0.01% | 241 |
|
|
2021
Q3 | $28K | Hold |
100
| – | – | 0.01% | 194 |
|
|
2021
Q2 | $35K | Hold |
100
| – | – | 0.01% | 185 |
|
|
2021
Q1 | $28K | Hold |
100
| – | – | 0.01% | 167 |
|
|
2020
Q4 | $24K | Hold |
100
| – | – | 0.01% | 161 |
|
|
2020
Q3 | $28K | Sell |
100
-100
| -50% | -$27.9K | 0.01% | 155 |
|
|
2020
Q2 | $54K | Hold |
200
| – | – | 0.02% | 133 |
|
|
2020
Q1 | $63K | Hold |
200
| – | – | 0.02% | 117 |
|
|
2019
Q4 | $59K | Buy |
+200
| New | +$55.5K | 0.02% | 122 |
|
|
2019
Q1 | – | Sell |
-38
| Closed | -$11K | – | 154 |
|
|
2018
Q4 | $11K | Hold |
38
| – | – | ﹤0.01% | 136 |
|
|
2018
Q3 | $13K | Hold |
38
| – | – | ﹤0.01% | 181 |
|
|
2018
Q2 | $11K | Hold |
38
| – | – | ﹤0.01% | 208 |
|
|
2018
Q1 | $10K | Hold |
38
| – | – | ﹤0.01% | 232 |
|
|
2017
Q4 | $12K | Hold |
38
| – | – | ﹤0.01% | 206 |
|
|
2017
Q3 | $12K | Hold |
38
| – | – | ﹤0.01% | 210 |
|
|
2017
Q2 | $10K | Hold |
38
| – | – | ﹤0.01% | 227 |
|
|
2017
Q1 | $10K | Sell |
38
-1
| -3% | -$283 | ﹤0.01% | 232 |
|
|
2016
Q4 | $11K | Buy |
39
+1
| +3% | +$296 | ﹤0.01% | 228 |
|
|
2016
Q3 | $12K | Hold |
38
| – | – | ﹤0.01% | 212 |
|
|
2016
Q2 | $9K | Buy |
+38
| New | +$10K | ﹤0.01% | 222 |
|
|
2016
Q1 | – | Sell |
-100
| Closed | -$31K | – | 206 |
|
|
2015
Q4 | $31K | Hold |
100
| – | – | 0.01% | 137 |
|
|
2015
Q3 | $29K | Hold |
100
| – | – | 0.01% | 142 |
|
|
2015
Q2 | $40K | Hold |
100
| – | – | 0.02% | 138 |
|
|
2015
Q1 | $42K | Hold |
100
| – | – | 0.02% | 134 |
|
|
2014
Q4 | $34K | Hold |
100
| – | – | 0.01% | 145 |
|
|
2014
Q3 | $33K | Buy |
+100
| New | +$33K | 0.01% | 154 |
|
Other funds holding BIIB
American National Bank & Trust's BIIB Position: Q3 2024 in Review
American National Bank & Trust sold out of Biogen (BIIB) in Q3 2024, closing a stake of 229 shares — an estimated $53.1K sold.
American National Bank & Trust first reported a position in BIIB in Q3 2014 and held it in 36 quarters. The position peaked at $63K in Q1 2020. 916 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.
- American National Bank & Trust reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
- American National Bank & Trust sold 229 Biogen shares in Q3 2024, an estimated $53.1K.
- American National Bank & Trust first reported a position in Biogen in Q3 2014 and held it in 36 quarters.
- American National Bank & Trust's Biogen position peaked at $63K in Q1 2020.
- 916 funds tracked by Wall St. Rank held Biogen as of Q3 2024.
Based on American National Bank & Trust's 13F filing for Q3 2024, filed 2 Oct 2024.